RedoxBiology1(2013)50–55 ContentslistsavailableatSciVerseScienceDirect Redox Biology journal homepage: www.elsevier.com/locate/redox Method Ferric chloride-induced murine carotid arterial injury: A model $ of redox pathology Wei Lia,b,n, Thomas M. McIntyrea,b, Roy L. Silversteinc aDepartmentofCellularandMolecularMedicine,LernerResearchInstitute,ClevelandClinic,9500EuclidAvenue,Cleveland,OH44195,USA bDepartmentofMolecularMedicine,ClevelandClinicLernerCollegeofMedicineofCase,WesternReserveUniversity,Cleveland,OH,USA cDepartmentofMedicine,MedicalCollegeofWisconsin,Milwaukee,WI,USA a r t i c l e i n f o a b s t r a c t Articlehistory: Ferric chloride (FeCl3) induced vascular injury is a widely used model of occlusive thrombosis that Received1November2012 reportsplateletactivationinthecontextofanasepticclosedvascularsystem.Thismodelisbasedon Receivedinrevisedform redox-induced endothelial cell injury, which is simpleand sensitive to both anticoagulant and anti- 13November2012 plateletsdrugs.Thetimerequiredforplateletaggregationtooccludebloodflowgivesaquantitative Accepted14November2012 measureofvasculardamagethatispathologicallyrelevanttothromboticdisease.Wehaverefinedthe traditional FeCl -induced carotid artery model making the data highly reproducible with lower 3 Keywords: variation. This paper will describe our artifices and report the role of varying the oxidative damage Ferricchloride byvaryingFeCl concentrationsandexposure.Toexploreamaximumdifferencebetweenexperimental 3 Thrombosis groups,adjustmentoftheselectedFeCl doseandexposuredurationmaybenecessary. Carotidartery 3 &2013TheAuthors.PublishedbyElsevierB.V.Allrightsreserved. Animalmodel Introduction guineapigsandrabbits[12–19].InthismodelFeCl isappliedtothe 3 topicalsurfaceofanintactvessel,triggeringvascularwallinjuryand Thromboticcardiovasculardiseasesarethemostcommoncause denudation of the endothelium via a mechanism involving the of death and disability in the developed world [1–4]. The vessel generation of reactive oxygen species [4,14]. A recent study sug- wall is a complex system that includes multiple cell types and is gested that FeCl -induced vascular injury was erythrocyte-depen- 3 influenced by multiple extrinsic factors including shear stress, dent,requiringhemolysisandhemoglobinoxidationforendothelial circulating blood cells, hormones and cytokines, as well as the denudation[20,21].Onemeasurableparameterinthismodelisthe antioxidant status of the vessel wall [5,6]. Therefore, in vitro elapsedtimefrominjurytocompletevesselocclusion,measuredas experiments cannot replicate this complex environment, so bloodflowcessationbyDopplerflowmeterorunderdirectobserva- invivostudiesofanimalmodelsarecriticaltoallowbetterunder- tionwithintravitalmicroscopy[13–15].Arangeoftimesbetween5 standing of mechanisms involved in thrombotic disorders [7–9]. and 30min has been reported in different studies in C57Bl6 mice Suchstudiesmimichumanpathologyandmayprovideimportant [12–15,22],suggestingthatFeCl concentrations,typesofanesthe- 3 mechanisticinformationrelatedtodiscoveryofnewpathwaysand sia, surgical techniques, mouse age and genomic background, drugs,aswellasimportantdetailscharacterizingdrugeffects. methodofmeasuringbloodflow,andotherenvironmentalvariables Ferric chloride (FeCl ) induced vascular injury is a widely used havesignificanteffectsinthismodel.Thiswidevariabilitymaybe 3 modelofthrombosis[10,11].Thisagent,appliedtotheouteraspect acceptable for a single study, but it makes it very difficult to ofarteriesinducesoxidativedamagetovascularcells[12,13],with comparestudiesfromdifferentgroupsandmaymakedetectionof loss of endothelial cell protection from circulating platelets and subtledifferencesdifficult.Inourrecentserialstudiesoftheroleof components of the coagulation cascade. This model is simple and thetype2scavengerreceptorCD36inthrombosisassociatedwith sensitive to both anticoagulant and anti-platelets drugs, and has diet-inducedatherosclerosiswe have refined the traditionalFeCl - 3 beenperformedoncarotidandfemoralarteries,jugularveins,and inducedcarotid arterymodelmakingthedatahighlyreproducible mesenteric and cremasteric arterioles and venules in mice, rats, with lower variation [12–15,22,23]. This paper will describe and shareourskillsandreportdifferentFeCl concentrationordifferent 3 treatingtimeinduceddifferentredoxinjuryonthrombosis. $This is an open-access article distributed under the terms of the Creative CommonsAttributionLicense,whichpermitsunrestricteduse,distribution,and reproductioninanymedium,providedtheoriginalauthorandsourcearecredited. Abbreviation:CA,carotidartery Materialsandmethods nCorresponding author at: Department of Cellular and Molecular Medicine, LernerResearchInstitute,ClevelandClinic,9500EuclidAvenue,Cleveland, OH44195,USA.Tel.:þ12164455492;fax:þ12164449404. All procedures and manipulations of animals have been E-mailaddress:[email protected](W.Li). approved by Institutional animal care and use committees 2213-2317/$-seefrontmatter&2013TheAuthors.PublishedbyElsevierB.V.Allrightsreserved. http://dx.doi.org/10.1016/j.redox.2012.11.001 W.Lietal./RedoxBiology1(2013)50–55 51 (IACUC) of The Cleveland Clinic in accordance with the United vein to label platelets using a 1cc syringe with a fresh 30G StatesPublicHealthServicePolicyontheHumaneCareandUseof needle.Itisimportanttoflushtheneedlewiththesolutionto Animals, and the NIH Guide for the Care and Use of Laboratory make sure that no air bubbles remain. To facilitate injection Animals. theneedlecanbebent2–3mmfromtiptoa901angle,which will make the tip parallel to the long axis of jugular vein Equipmentandreagents (Fig. 1D). To stabilize the syringe and keep the needle in positionthesyringeisheldinonehandandtheneedlewitha ToolsformousesurgeryareavailablefromFineScienceTools forceps in the other during the injection.After injection, the (FST). Minimum necessary tools include: dissection scissor site is held with the forceps, the vessel is clamped with a (14502-14), forceps (11018-12) for cutting skin, scissor (14519- dissection forceps, and the vein is ligated with a 6-0 suture. 14)andforceps(11050-10)fordissectingsofttissue,hemostatic It is important to perform the rhodamine injection before forceps (13021-12), fine needle holders (12061-10), fine tip exposingtheleftcarotidartery(CA)topreventadventitialCA forceps [Dumont #5 (11cm) 11254-20 and Dumont #5XL stainingbythefluorescentdyeifleakageorbleedingoccurred (15cm) 11253-10], 3/8 curve needle, 4-0 silk suture, 6-0 silk duringorafterinjection. suture, and a hook (10062-12). A black plastic coffee stir tube, 9. Thesofttissueandfasciaaroundtheleftsubmaxillarygland Whatman#1filterpapercutinto1(cid:2)2mmpieces,15-cmtissue is then dully dissected and pulled toward the 7 o’clock culturelids,surgicaltape,adissectingmicroscope(orloupeswith position (Fig. 1E) to expose the left sternocleidomastoid at least 4X magnifications), heating pad withrectal temperature muscle(bluearrow). monitor probe, and hair cutter were also used. For real time 10. The fascia (Fig. 1E, dotted line) between the left sternoclei- observation of thrombosis we used a Leica DMLFS fluorescent domastoid muscle and the omohyoid muscle or the sterno- microscope with an attached Gibraltar Platform (EXFO, Quebec, hyoidmuscle(Fig.1E,greenarrow)locatedtotheleftofthe Canada) and water immersion objectives at 10x, 20x and 60x tracheaisthendullydissectedwithahemostaticforceps. magnifications. Video imaging was performed using a QImaging 11. A needle with 6-0 silk suture (about 15cm long) is passed Retigo Exi 12-bit mono digital camera (Surrey, Canada) and under the sternocleidomastoid muscle at the level indicated Streampix version 3.17.2 software (Norpix, Montreal, Canada). by blue arrow in Fig. 1E and pulled laterally toward the Ketamine(Ketaset100mg/ml,FortDodgeAnimalHealth,IA,USA) 10o’clockpositiontoexposethecommonCAalongorunderthe andxylazine(100mg/ml,Hospira,IL,USA)wereusedforanesthe- sternohyoid muscle and/or omohyoid muscle. This procedure sia and rhodamine 6G (Sigma 252433-1G, 0.5mg/ml in saline, mustbeperformedwithcaretoavoidinjuringtheleftjugular 0.2mm filtered) was injected intravenously used to label blood vein, which is located outside of the sternocleidomastoid components. A stock solution of 30% FeCl (Anhydrous, Sigma muscle. 3 12321) in water was prepared and diluted prior to use at final 12. The CA is seen after pulling away the sternocleidomastoid concentrationsof2.5%,5%,7.5%,10%and12.5%. muscle (Fig. 1F arrow), which is accompanied by the vagus nerve, the white structure seen in Fig. 1G (green arrow). Arterialinjuryprotocol The very thin omohyoid muscle seen between the yellow dottedlinesinFig.1FisremovedifitcoverstheCA. 1. EighttotwelveweeksoldC57Bl6miceareanesthetizedwith 13. The hemostatic forceps are used to dissect the soft tissue ketamine (100mg/kg)/xylazine (10mg/kg) via intraperito- around the CA without touching the CA, and then fine tip neal injection. This anesthetic method facilitates manipula- forceps are used to pick up the lateral fascia around the CA tion of the animal during surgery and during transfer from while avoiding the vagus nerve and CA. Another fine tip surgicalbenchtothemicroscopestage. forcepisthenusedtopunchaholebetweentheCAandvagus 2. Fur on the neck and upper chest is removed with a small nerve. A hook is passed through the hole and the CA gently animalelectricclipper.Dipilatorycreamisnotused. lifted so that a fine tip forcep can be placed under the CA. 3. Mice are secured in the supine position on the lid of 15cm The hook and forceps are then in opposite directions along tissue culture plate using tape (about 10cm) to secure hind theCAtostripadventitialsofttissue. limbsandlowerbody,andtwopiecesoftape(2cm(cid:2)0.5cm) 14. To block background fluorescence, a black plastic coffee to secure the forelegs. A 4-0 suture is wrapped around the stirreriscutintoa3mmpiece,pressedandcutlongitudinally incisorstokeeptheneckstraight. toyieldtwopiecesof‘‘U’’shapeplastic.Onepieceisinserted 4. The mouse is placed with head towardsthe operator under a withforcepsundertheCAwhilegentlyliftingtheCAwiththe surgical light source. A midline incision is made through the hook(Fig.1H). skinfromsternumtochinasshowninthelinedrawninFig.1A. 15. ToavoiddryingofCA,2–3dropsofsalineareappliedtothe 5. The structures visualized first under the skin are the sub- surgical field and the mouse and plate lid are transferred maxillaryglands(Fig.1BandD,bluearrows)whicharelinked together to the microscope stage and the 10x water lens is byathinfascia(dottedline).Thisfasciacanbedullydissected placedintheappropriateposition. with a hemostatic forceps exposing the manubrium (black 16. Sincemechanicaltraumacandirectlyinjuretheendothelium arrowinFig.1C)andthetrachea(TinFig.1D). and lead to thrombus formation [24] it is necessary to 6. ThesofttissueseentotherightoftheblackarrowinFig.1C observeandrecordvesselimagestoconfirmthatnosurgical andtheskinareheldtogetherwithaforcepsandadissection injuryhappenstothevesselpriortotheFeCl injury.Itisalso 3 forcepsistheninsertedunderthefasciatowardthe2o’clock necessarytoconfirmthatthereisnoremainingtissuearound position(yellowdottedlineinFig.1C)whichisthepositionof theCA,whichmayformabarrierandattenuatetheeffectof theclavicle.Thefasciaisthenfreedfromthejugularveinby FeCl -inducedinjury. 3 openingtheforceps. 17. Apapertowelisfoldedtomakeathinandfinetipandusedto 7. Thefascia,softtissueandskinalongtheyellowdottedlinein carefullyblotthesalinearoundtheCA(avoidtouchingCA)as Fig. 1C are cut to expose the right jugular vein (Fig. 1D, well as in other places in the surgical field. This is very arrow). importanttoavoiddilutionoftheusedFeCl solution. 3 8. 100ml of rhodamine 6G solution (or other drugs or fluores- 18. Using a fine tip forceps to pick up a piece of filter paper centfree radicalindicators) is injectedinto theright jugular (1(cid:2)2mm) saturated with FeCl solution and place directly 3 52 W.Lietal./RedoxBiology1(2013)50–55 Fig.1. Procedurestoexposethejugularvein,injectionofrhodamine6Gflurescencedyeintothecirculationsystemandexposureofleftcarotidartery.Tindicatestrachea. Seetextfordetails. ontheCAfortimedpoints.Thenthefilterpaperisremoved segmentitbecomesdifficulttoidentifybloodflowinthethrombi. fromtheCAandrinsedwithsaline.Toaidvisualizationofthe To solve this issue the imaging is moved to the proximal un- bloodstreamthefilterpaperisplacedtowardthedistalend injuredsite(Fig.1I,greenarrow).Inthissite,bloodflowshouldbe of the exposed CA (Fig. 1I) making sure to leave a short stillclearlyidentified.Theendpointsoftheexperimentare:when segment of the proximal site (green arrow in Fig. 1I) for bloodflowhasceasedfor 430s,orifocclusionisnotseenafter observinglatephasebloodflow. 30min,thetimeisrecordedas30minforstatisticalcomparisons. Observationofthrombiformationandtheimagerecord Statisticalanalysis Thrombus formation is identified by accumulation of the One-way ANOVA (Bonferroni/Dunn) is used to determine the fluorescent platelets, which is observed in real-time recording differences among groups. Unpaired t test is used to determine videoimagesorundermicroscope.Typically,werecordvideofor differencesbetweengroups.Dataarerepresentedasmean7SEM, 10s everyminutefor thefirst 10min and then10severy other andPo0.05isconsideredsignificant. minute.Makesuretonotethevideoframenumberateachtime point for later analysis. After injury the vessel is scanned from Resultsanddiscussion distal to proximal sites of the exposed segments to provide a completeviewoftheinitialinjury,andthenfocusontheinterest Animal models of thrombosis not only provide valuable areaforfurtherimaging.Whenthethrombusoccupiestheentire informationaboutthemechanismsofthrombosis,butalsoarea W.Lietal./RedoxBiology1(2013)50–55 53 Before 1 4 8 12 16 20 24 28 30 wt cd36-/- Before 1 2 4 6 8 10 12 14 30 wt stopped cd36-/- no stop Before 1 2 4 6 8 10 11 24 28’30” wt stopped cd36-/- stopped Before 1 2 3 4 5 6 6’45” stopped wt cd36-/- stopped Fig. 2. Effect of different concentration of FeCl3 on thrombosis. Representative video images of thrombi formation in carotid artery (CA) treated with different concentrationofFeCl3,2.5%(A),5%(B),7.5%(C),and10%(D)areshown.Bloodflowwasfromrighttoleft.‘‘Before’’indicatesimagestakenimmediatelypriortoFeCl3 treatment.Numbersindicatetimeinminutesafterremovingthefilterpaper.ArrowsinAindicatethetinythrombiwhichwerefirstobserved. valuable tool for pre-clinical evaluation of compounds that may which are unable to bind and respond to oxidized lipoprotein be used for treatment and prevention of the atherothrombotic particlesandapoptoticcellparticles,astoolstocomparedifferent diseases [10,16,21,25]. Although the FeCl induced vessel injury concentrationofFeCl onthrombosis.Nothrombiwereobserved 3 3 model is a well-accepted tool for studying thrombosis, the in the absence of FeCl application, showing that the surgical 3 mechanismofFeCl inducedvascularlesionandthedeterminants procedures did not induce vascular injury (Fig. 2). Treatment of 3 initiatingthrombusformationremainsincompletelyunderstood. CA with 2.5% FeCl for 1min immediately induced formation of 3 OneestablishedconceptisthatFeCl mediatedoxidationinduces scatteredtinythrombiinwtmice(Fig.2A,column1min,arrows). 3 endothelial cell denudation and subsequent exposure of the Withtime,thethrombibecamelarger,butat30minthosewere subendothelial matrix to the blood stream, thus activating the not large enough to impact blood flow. There were no thrombi coagulatingsystem[4,21]. formedin2ofthe3cd36nullmiceandonly4tinythrombiwere We made several refinements to the FeCl model to enhance observed(startingat8min)inthethirdmouse. 3 itsutilityandreproducibility.Theseinclude:(1)exposingtheCA Treatment with 5% FeCl for 1min immediately induced 3 sufficientlytoprovideenoughlength((cid:3)5mm)toallowapplica- thrombi formation in wt and cd36 null mice, and the border of tion of the filter paper while leaving space to clearly observe the injured area was easy to identify (not shown). The thrombi bloodflowbyintravitalmicroscopy;(2)strippingtheadventitial formed initially were smaller in cd36 null mice than in wt mice soft tissue cleanly around the CA to allow the filter paper (Fig. 2B). These initial thrombi were washed away by the blood to contact the vessel wall directly and produce an even injury; stream,sofewerthrombiwereseenat2min.Thrombistartedto (3)underlyingtheCAwitha‘‘U’’shapedpieceofblackplasticto enlarge 3–4min after removing the filter paper and these later separate it from surroundingtissue, preventFeCl diffusion, and forming thrombi were stable and usually did not wash away. 3 block background fluorescence. This strategy is very important Thethrombiinwtmiceformedfasterandwerelargerthanthose when using this model to examine vessel wall reactive oxygen in cd36 null mice; cessation of blood flow was seen in 3 of the species formation by injection of free radical indicator into the 5wtmicewithanaveragevesselocclusiontimeof23minwhile blood system [26]; (4) directly injecting a fluorescence dye into none of the cd36 null mice showed flow cessation within the the jugular vein to label platelets in vivo. This does not affect 30minofobservation. platelet count or function, and obviates the need to sacrifice Treatment of the vessels with 7.5% FeCl induced more rapid 3 additionalanimalsasplateletdonors. increase in the size of thrombi in wt mice, but had no obvious differenceincd36nullmice(Fig.2C).Asreportedpreviously[27], DosedependenceofFeCl -inducedvesselocclusiontime thisconcentrationofFeCl inducedvesselocclusioninbothtypes 3 3 of mice; however, the vessel occlusion time was significantly We previously have reported that deletion of cd36 prolonged elongated in cd36 null mice. When the FeCl concentration was 3 vesselocclusiontimes[13].Wenowusedwtandcd36nullmice, 10% or greater the vessel wall oxidation injury was presumably 54 W.Lietal./RedoxBiology1(2013)50–55 maximal(Fig.2D)andnodifferencesinocclusiontimewereseen When thrombi become larger and cover the entire area of betweenthetwotypesofmice.Fig.3showsvesselocclusiontime injury,itbecomesdifficulttoobserveflow(e.g.Fig.2B,8mintime plottedasafunctionofFeCl anddemonstratesashifttotheright pointinwt,andonlinevideo).Thismaybethereasonwhysome 3 oftheresponsecurveincd36nullmicecomparedtowt,suggest- researchersthinkthatthismethodislesssensitivethanmeasure- ing a pro-thrombotic effect of CD36. These data are also consis- mentofbloodflowbytransonicflowmeter.Bysurgicallyexposing tent with our recent data that cd36 deletion induced an theCAoverasufficientlengthandplacingthefilterpapercloseto antioxidanteffectonthevesselwall[14]. the distal site (Fig. 1I) we were able to observe and record the normal area proximal to the site of injury as shown in Fig. 1I (arrow) and Fig. 2C (e.g. 6–11min in 7.5% FeCl treated wt 3 32.5 * mouse), and blood flow can be identified clearly. When blood flowceases,numerouslargercells(leukocytes)starttoadhereto 30 * the vessel wall at the proximal site of the thrombi; therefore, 27.5 p = 0.02 p = 0.04 large cell accumulation can be used as a secondary marker for min) 25 oxidatvevasculardamage.Flowusuallystoppedwithin2minof m ( 22.5 theappearanceoflargecells(seeonlinevideoformoreinforma- n ti 20 tion). In our studies we recorded the time when blood flow sio 17.5 completely stopped. This may differ from some studies using a clu 15 p<0.0001 p<0.0001 transonicflowprobewherebackgroundnoisemakesitdifficultto c o determinetheflowprecisely,especiallywhenitfallstolessthan sel 12.5 10%ofbaseline[28]. Ves 10 Supplementary material related to this article can be found 7.5 onlineathttp://dx.doi.org/10.1016/j.redox.2012.11.001. wt 5 2.5 cd36-/- ThedurationofFeCl3treatmentcorrelateswithtimetovessel 0 occlusion FeCl (%) 2.5 5 7.5 10 12.5 3 PublishedstudieshaveusedarangeofexposuretimesofFeCl 3 Fig.3. VesselocclusiontimesafterdifferentconcentrationsofFeCl3treatment. treatment,makingcomparisonsamongstudiesdifficult.Todeter- MiceweretreatedasinFig.2andocclusiontimeassessedbyintravitalmicro- mine the effect of varying exposure times in this model system scopy. *po0.01 wt vs. cd36 null at the same concentration of FeCl3. One-way we treated cd36 null mice with 5% FeCl for 1, 3 and 5min. ANOVABonferroni/Dunnwasusedtodeterminethedifferencesamonggroups. 3 Dataarerepresentedasmean7SEM.N¼3for2.5%FeCl3treatedwtandcd36null As shown in Fig. 4, increasing the duration of FeCl3 exposure mice;n¼4for5%FeCl3treatedcd36nullmice;andn¼5inallotherconditions. dramatically increased the rate of thrombus enlargement and Before 1 2 4 8 12 16 20 24 30 1 min no stop 3 min 5 min 8’30” stopped p = 0.006 p = 0.2 35 p = 0.02 30 n) mi m ( 25 n ti 20 o si u cl 15 c o sel 10 s Ve 5 0 1 3 5 FeCl 5% (min) 3 Fig.4. DurationofFeCl3treatmentonthrombosis.(A)RepresentativevideoimagesofthrombiinCAexposedto5%FeCl3for1,3or5min.‘‘Before’’indicatesbeforeFeCl3 treatment.Numbersindicatetimeinminutesafterremovingthefilterpaper.(B)Statisticalanalysisofvesselocclusiontime.N¼3for1minandn¼5for3and5min treatments.One-wayANOVA(Bonferroni/Dunn)wasusedtodeterminethedifferencesamonggroups.Dataarerepresentedasmean7SEM. W.Lietal./RedoxBiology1(2013)50–55 55 shortened the time to blood flow cessation. We previously [8] T. Thijs, H. Deckmyn, K. Broos, Model systems of genetically modified showed that cd36 deletion protects VSMC from oxidant stress platelets,Blood119(7)(2012)1634–1642. [9] R.J.Westrick,M.E.Winn,D.T.Eitzman,Murinemodelsofvascularthrombosis andreducestheamountofmicroparticlesinthecirculationafter (Eitzmanseries),Arteriosclerosis,Thrombosis,andVascularBiology27(10) FeCl3 injury. We also showed that microparticles contribute to (2007)2079–2093. thrombosis by interacting with platelet CD36 [13]. Others have [10] S.M.Day,J.L.Reeve,D.D.Myers,W.P.Fay,Murinethrombosismodels,Journal shown that FeCl -injury induces release of endothelial cell- ofThrombosisandHaemostasis92(3)(2004)486–494. 3 [11] H.C.Whinna,Overviewofmurinethrombosismodels,ThrombosisResearch derivedFeCl -filled‘‘buds’’thatarerichintissuefactorandmay 3 122(1)(2008)S64–S69. contribute to thrombosis [21], while VSMC-derived tissue factor [12] K. Chen, W. Li, J. Major, S.O. Rahaman, M. Febbraio, R.L. Silverstein, Vav can contribute to macrovascular thrombosis [29]. Our data guaninenucleotideexchangefactorslinkhyperlipidemiaandaprothrombo- suggest that the duration of FeCl exposure is an important ticstate,Blood(2011)22. 3 [13] A.Ghosh,W.Li,M.Febbraio,R.G.Espinola,K.R.McCrae,E.Cockrell,etal., component of the injury response in mouse models, perhaps by PlateletCD36mediatesinteractionswithendothelialcell-derivedmicropar- influencing the level of endothelial and VSMC injury and micro- ticlesandcontributestothrombosisinmice,JournalofClinicalInvestigation particlesreleaseafterexposingthevesseltooxidativestress. 118(5)(2008)1934–1943. [14] W.Li,M.Febbraio,S.P.Reddy,D.Y.Yu,M.Yamamoto,R.L.Silverstein,CD36 Insummary,wehaverefinedandstandardizedcomponentsof participatesinasignalingpathwaythatregulatesROSformationinmurine the FeCl3-indcued vascular injury model to produce a highly VSMCs,JournalofClinicalInvestigation120(11)(2010)3996–4006. reproducibleinjuryresponsewherewecanquantitatebloodflow [15] K. Chen, M. Febbraio, W. Li, R.L. Silverstein, A specific CD36-dependent cessationaccuratelybyintravitalmicroscopy.Thisallowedusto signalingpathwayisrequiredforplateletactivationbyoxidizedlow-density lipoprotein,CirculationResearch102(12)(2008)1512–1519. generate reproducible results with low variance [4,12–15,22,30] [16] K.D. Kurz, B.W. Main, G.E. Sandusky, Rat model of arterial thrombosis to demonstrate FeCl3 dose and exposure duration, and hence inducedbyferricchloride,ThrombosisResearch60(4)(1990)269–280. oxidativeinsult,influencesthrombosisinvivo. [17] S.Konstantinides,K.Schafer,T.Thinnes,D.J.Loskutoff,Plasminogenactivator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascularinjuryinmice,Circulation103(4)(2001)576–583. [18] R.J.LeadleyJr.,S.R.Morgan,R.Bentley,J.S.Bostwick,C.J.Kasiewski,C.Heran, Contributionofauthors etal.,PharmacodynamicactivityandantithromboticefficacyofRPR120844, anovelinhibitorofcoagulationfactorXa,JournalofCardiovascularPharma- Dr.Liperformedtheexperiments,dataanalysisandwrotethe cology34(6)(1999)791–799. [19] E.MarshLyle,S.D.Lewis,E.D.Lehman,S.J.Gardell,S.L.Motzel,J.J.LynchJr., paper. Dr. McIntyre and Dr. Silverstein contributed to read and Assessment of thrombin inhibitor efficacy in a novel rabbit model of writethepapercritically. simultaneous arterial and venous thrombosis, Journal of Thrombosis and Haemostasis79(3)(1998)656–662. [20] K.J.Woollard,S.Sturgeon,JPChin-Dusting,H.H.Salem,S.P.Jackson,Erythrocyte Conflictofintereststatement hemolysisandhemoglobinoxidationpromoteferricchloride-inducedvascular injury,JournalofBiologicalChemistry284(19)(2009)13110–13118. [21] A. Eckly, B. Hechler, M. Freund, M. Zerr, J.P. Cazenave, F. Lanza, et al., Theauthorshavenoconflictsofinterestrelatedtothisstudy. Mechanisms underlying FeCl3-induced arterial thrombosis, Journal of ThrombosisandHaemostasis9(4)(2011)779–789. [22] J.O.Robertson,W.Li,R.L.Silverstein,E.J.Topol,J.D.Smith,DeficiencyofLRP8 Acknowledgment inmiceisassociatedwithalteredplateletfunctionandprolongedtimefor invivothrombosis,ThrombosisResearch123(4)(2009)644–652. [23] W. Zhu, W. Li, R.L. Silverstein, Advanced glycation end products induce a ThisstudywassupportedbyNIHgrantsHL81011andHL092747 prothromboticphenotypeinmiceviainteractionwithplateletCD36,Blood (toR.L.Silverstein). 119(25)(2012)6136–6144. [24] R.LeMenn,L.Bara,M.Samama,Ultrastructureofamodelofthrombogenesis induced by mechanical injury, Journal of Submicroscopic Cytology 13 (4) References (1981)537–549. [25] B.C.Cooley,Murinemodelsofthrombosis,ThrombosisResearch129(2)(2012) S62–S64. [1] J.Sanz,P.R.Moreno,V.Fuster,Theyearinatherothrombosis,Journalofthe [26] W.Li,M.Febbraio,S.P.Reddy,D.Y.Yu,M.Yamamoto,R.L.Silverstein,CD36 AmericanCollegeofCardiology60(10)(2012)932–942. participatesinasignalingpathwaythatregulatesROSformationinmurine [2] T.A.Meadows,D.L.Bhatt,Clinicalaspectsofplateletinhibitorsandthrombus VSMCs,JournalofClinicalInvestigation120(11)(2010)3996–4006. formation,CirculationResearch100(9)(2007)1261–1275,May11. [27] A.Ghosh,W.Li,M.Febbraio,R.G.Espinola,K.R.McCrae,E.Cockrell,etal., [3] D.O.Abegunde,C.D.Mathers,T.Adam,M.Ortegon,K.Strong,Theburdenand costsofchronicdiseasesinlow-incomeandmiddle-incomecountries,Lancet PlateletCD36mediatesinteractionswithendothelialcell-derivedmicropar- 370(9603)(2007)1929–1938. ticles and contributes to thrombosis in mice, The Journal of Clinical [4] R.L.Silverstein,W.Li,Y.M.Park,S.O.Rahaman,Mechanismsofcellsignaling Investigation118(5)(2008)1934–1943. bythescavengerreceptorCD36:implicationsinatherosclerosisandthrom- [28] A.P. Owens 3rd, Y. Lu, H.C. Whinna, C. Gachet, W.P. Fay, N. Mackman, bosis,TransactionsoftheAmericanClinicalandClimatologicalAssociation Towards a standardization of the murine ferric chloride-induced carotid 121(2010)206–220. arterial thrombosis model, Journal of Thrombosis and Haemostasis 9 (9) [5] I.M.Fearon,S.P.Faux,Oxidativestressandcardiovasculardisease:noveltools (2011)1862–1863. give(free)radicalinsight,JournalofMolecularandCellularCardiology47(3) [29] L. Wang, C. Miller, R.F. Swarthout, M. Rao, N. Mackman, M.B. Taubman, (2009)372–381. Vascularsmoothmuscle-derivedtissuefactoriscriticalforarterialthrom- [6] P.Libby,Inflammationinatherosclerosis,Nature420(6917)(2002)868–874. bosisafterferricchloride-inducedinjury,Blood113(3)(2009)705–713. [7] G. Vilahur, T. Padro, L. Badimon, Atherosclerosis and thrombosis: insights [30] J.Liu,W.Li,R.Chen,T.M.McIntyre,Circulatingbiologicallyactiveoxidized fromlargeanimalmodels,JournalofBiomedicineandBiotechnology2011 phospholipidsshowon-goingandincreasedoxidativestressinoldermale (2011)907575. mice,RedoxBiology(2013).